Hemab chairman John Maraganore (Ryan Emberley/Getty Images for Klick Inc.)

Rare blood dis­or­ders biotech Hemab rais­es $135M, be­gins trek in­to clin­ic

Hemab Ther­a­peu­tics, led by Al­ny­lam vet Ben­ny Sorensen and chaired by John Maraganore, has raised $135 mil­lion from a new crop of in­vestors as it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.